To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM
Clinical trial NCT05814406 · COMPLETED
Trial details
- NCT number
- NCT05814406
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-12
- Primary completion
- 2024-03-21
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.